AUROLIFE PHARMA LLC
GenericsAUROLIFE PHARMA LLC is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Immunology.
AUROLIFE PHARMA LLC's Key Drugs
AUROLIFE PHARMA LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
AUROLIFE PHARMA LLC's Recent FDA Approvals
New NDA/BLA approvals for AUROLIFE PHARMA LLC over the last two years — novel drugs only, excluding generics and label supplements.
AUROLIFE PHARMA LLC's Therapeutic Areas
AUROLIFE PHARMA LLC's approved drugs and pipeline span 4 therapeutic areas, led by Cardiovascular and Gastroenterology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AUROLIFE PHARMA LLC's Top Competitors
AUROLIFE PHARMA LLC's closest competitors by therapeutic-area and drug-target overlap include Takeda, Johnson & Johnson, and Amgen. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
AUROLIFE PHARMA LLC Pipeline Snapshot
Active clinical trials for AUROLIFE PHARMA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1972-12-20
- Latest
- 2026-06-18
- Applications
- 29